Eli Lilly (LLY)
$110.89 0.58 (0.52%)
18:30 EDT LLY Stock Quote Delayed 15 Minutes
Previous Close $110.89
Market Cap 120.36B
PE Ratio 103.64
Volume (Avg. Vol.) 2.84M
Day's Range 110.24 - 112.15
52-Week Range 104.17 - 132.13
Dividend & Yield 2.25 (2.03%)
LLY Stock Predictions, Articles, and Eli Lilly News
- From InvestorPlace
- From the Web
Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.
The stock charts of Eli Lilly, SYSCO and Interpublic Group are knocking on the door of some trade-worthy moves.
The stock charts of LLY, BA and HRB are moving into pivotal positions as the trading week starts to wind down.
The stock charts of HRL, JNPR and LLY stock are moving into the midpoint of the week on the cusp of something trade-worthy.
Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.
AZN stock is great to own, but you should choose your entry points carefully, as AstraZeneca has some short-term risks ahead.
The bull thesis in Eli Lilly stock has strong qualitative and quantitative support, making it pretty hard to refute or ignore.
A recent article in the investment media asked if Pfizer stock was a better buy than Eli Lilly stock. Here’s why I wouldn’t buy either.
In 2018, Humalog generated $3.0 billion for Eli Lilly, 5% higher than a year earlier. Assuming Humalog’s gross margin is 73.8% (I’m using the company’s overall gross margin; it’s likely higher), Eli Lilly had $2.2 billion in gross profits from this single drug. Except for Trulicity, the company’s bestselling diabetes drug, Humalog is the company’s second-largest revenue and profit generator.
The stock charts of PPL, CF and DHI are all on the precipice of major moves, though each one has one more hurdle to clear.
The stock charts of LLY, LKQ and CNC deserve a closer look through a technical trading lens as the trading week winds down.
Options trading was abuzz in Eli Lilly, Twitter and Freeport-McMoRan on Wednesday. Here are the metrics and levels that matter here.
In the latest Eli Lilly news, LLY stock fell more than 2% as the company's late-stage trial of a sarcoma study failed to meet its goals.
Pharmaceutical stocks have been on the rebound and many are raising their prices this year. What does that mean for business?
Roku soared, while the S&P 500, Twilio, Eli Lilly and Nvidia all perked up as well. Here are a few must-see stock charts for Tuesday.
Loxo Oncology (LOXO) stock was flying high on Monday following news of an $8-billion deal between it and Eli Lilly (LLY).
LLY stock is worth a look after Eli Lilly claims its new drugs may provide 45% of 2019 revenue and it can afford to raise its dividend 15%.
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!